Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medicis Pharmaceutical
AddedFeb 19, 2024
UpdatedJun 28, 2026
Medicis Pharmaceutical

Medicis Pharmaceutical

Acquired

Leading medical cosmetics provider specializing in acne and facial wrinkle treatments.

HQ
Scottsdale, AZ, US
Founded
1988
Overview
Compare
Employees

Medicis Pharmaceutical, based in Bridgewater, New Jersey, focuses on medical cosmetics, specializing in acne and facial wrinkle treatments. As a subsidiary of Valeant Pharmaceuticals since 2012, it offers products like Solodyn and Ziana for acne, and Restylane and Dysport for facial wrinkles.

Medicis has significantly impacted the medical cosmetics market with its innovative treatments. Its products are widely recognized for their effectiveness, contributing to the company's reputation as a leader in dermatological solutions.

Medicis Pharmaceutical - Similar Companies

Skin Pharm logo

Skin Pharm

skinpharm.com

Dermamedics logo

Dermamedics

dermamedics.com

Cosmederm Bioscience logo

Cosmederm Bioscience

Revance Therapeutics logo

Revance Therapeutics

revance.com

Curology logo

Curology

curology.com

Medicreations logo

Medicreations

medicreations.com

MD Complete logo

MD Complete

mdcomplete.com

Aesthetics Biomedical logo

Aesthetics Biomedical

Zaina Pharma logo

Zaina Pharma

Dermavant Sciences logo

Dermavant Sciences

Medytox logo

Medytox

medytox.com

Mdrejuvena logo

Mdrejuvena

Enhance Skin Products logo

Enhance Skin Products

Encore Dermatology logo

Encore Dermatology

Renew You Medspa logo

Renew You Medspa

Medicis Pharmaceutical - Quick Facts

Who are Medicis Pharmaceutical's competitors?

Companies similar to Medicis Pharmaceutical include Skin Pharm, Dermamedics, Cosmederm Bioscience and Revance Therapeutics.

When was Medicis Pharmaceutical founded?

Medicis Pharmaceutical was founded in 1988.

Where is Medicis Pharmaceutical's headquarters located?

Medicis Pharmaceutical's headquarters is located in Scottsdale, AZ, US.

Medicis Pharmaceutical - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Cosmetics
  • Skincare
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 15 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 4000Railroad Transportation
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 6201Computer programming activities